Brief: Bavarian Nordic Partners With Biological E To Expand Global Access To Chikungunya Vaccine

Bavarian Nordic A/S

25/02/2025 06:11

Feb 25 (Reuters) - Bavarian Nordic A/S  BAVA.CO :
    * PARTNERS WITH BIOLOGICAL E LIMITED TO EXPAND GLOBAL ACCESS
TO
CHIKUNGUNYA VACCINE
    * INITIALLY, COMPANIES HAVE ENTERED INTO A CONTRACT
MANUFACTURING
AGREEMENT TO ALLOW FOR SCALING OF CAPACITY TO ENABLE FUTURE
SUPPLY TO ENDEMIC LMIC COUNTRIES
    * THIS AGREEMENT COMPRISES A TECHNOLOGY TRANSFER OF CURRENT
DRUG
PRODUCT MANUFACTURING PROCESS FOR CHIKUNGUNYA VACCINE, WITH
OPTION TO TRANSFER DRUG SUBSTANCE PROCESS AT A LATER STAGE
    * BAVARIAN NORDIC RETAINS ITS OWN MANUFACTURING CAPACITY FOR
FORTHCOMING COMMERCIALIZATION OF VACCINE IN WESTERN MARKETS

Source text:  ID:nGNE9J9fZF 
Further company coverage:  BAVA.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))